Adderall is also known to reduce feelings of hunger and increase energy levels, both of which can contribute to weight loss
Subjects were excluded if they had clinically significant concomitant diseases or disorders, clinically significant abnormal values in clinical laboratory screening tests, any history of gastrointestinal surgery, had used any prescription or non-prescription drugs within 3 weeks prior to dosing of trial product (except hormone replacement therapy, contraceptives and occasional use of paracetamol in the food-effect trial), were smokers (dosing conditions trial) or were not able or willing to refrain from smoking while staying at the clinic (food-effect trial), or if they were pregnant or breastfeeding women (food-effect trial)
Alcohol, in particular, requires a massive amount of glutathione for the liver to process
These changes were statistically significant and potentially clinically meaningful, as even modest blood pressure reductions of this magnitude are associated with reduced cardiovascular event rates at a population level
Adderall is prescribed for attention deficit hyperactivity disorder and narcolepsy
The following antibodies were used: PCSK5 (Abcam, Cambridge, UK, #ab39873)